Kalaris Therapeutics, Inc. (KLRS) — Defensive Interval Ratio
Kalaris Therapeutics, Inc. (KLRS) has a Defensive Interval Ratio of 2837 days as of March 2026. Defensive assets of $62.79 Million (cash $-, short-term investments $62.79 Million, receivables $-) cover 2837 days of daily cash needs of $22.13K/day. See KLRS working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Kalaris Therapeutics, Inc. Defensive Interval Ratio (2018–2025)
This chart shows how Kalaris Therapeutics, Inc.'s Defensive Interval Ratio has evolved across 6 annual periods from 2018 to 2025. As of March 2026, the ratio stands at 2837 days, meaning defensive assets of $62.79 Million can fund 2837 days of operations without new revenue. See KLRS equity financing ratio to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Kalaris Therapeutics, Inc. (2018–2025)
The table below presents the year-by-year Defensive Interval Ratio for Kalaris Therapeutics, Inc. from 2018 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is Kalaris Therapeutics, Inc. worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 749 days | $19.93 Million | $26.61K/day | $- | $19.93 Million | ▲ +749 days |
| 2024 | 0 days | $0.00 | $14.35K/day | $- | $0.00 | ▼ -448 days |
| 2021 | 448 days | $46.51 Million | $103.71K/day | $- | $46.46 Million | ▼ -6502 days |
| 2020 | 6951 days | $234.11 Million | $33.68K/day | $- | $233.66 Million | ▲ +4323 days |
| 2019 | 2628 days | $65.55 Million | $24.95K/day | $- | $64.99 Million | ▲ +2598 days |
| 2018 | 29 days | $302.00K | $10.24K/day | $- | $- | — |